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Introduction
Lead is an industrial and environmental pollutant that can 
cause pathological changes to multiple organ systems, 
including the nervous system. Lead has irreversible neuro-
toxic effects on the developing brain (Wang et al. 2008). 
However, the molecular mechanisms of lead-induced neu-
rotoxicity remain unclear. There have been few studies 
investigating the role of non-coding RNAs (ncRNAs) in 
this process, although they have been shown to play impor-
tant roles in many biological processes, including tran-
scriptional regulation, DNA replication, RNA processing, 
mRNA stability and translation, and protein degradation 
and transport (Storz 2002).
Long non-coding RNAs (lncRNAs) and circular RNAs 
(circRNAs) have been the focus of many recent studies on 
ncRNA function. LncRNAs are 200 nucleotides in length 
and are distributed in the nucleus or cytoplasm (Maruyama 
and Suzuki 2012; Okazaki et al. 2002). LncRNAs regu-
late gene expression at the transcriptional, post-transcrip-
tional, and epigenetic levels and have been implicated in 
species evolution, embryonic development, metabolism 
and disease (Mercer et al. 2009; Taft et al. 2010). On the 
other hand, knowledge of circRNA functions is limited. 
These molecules were originally identified in an RNA 
virus (Wilusz and Sharp 2013); they are widely present in 
mammalian cells and have been linked to the regulation of 
gene expression (Zhang et al. 2014), alternative splicing 
(Lasda and Parker 2014), and translation through interac-
tion with RNA-binding proteins (Zhang et al. 2013). Cir-
cRNAs have been shown to bind microRNAs (miRNAs) as 
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sponges, thereby indirectly regulating target gene expres-
sion (Hansen et al. 2013a; Wilusz and Sharp 2013). There 
have been no reports to date of interactions between lncR-
NAs and circRNAs.
The present study investigated the functions of lncRNAs 
and circRNAs in lead-induced neurotoxicity. We first car-
ried out an RNA screen in a mouse model. A quantitative 
real-time polymerase chain reaction (qRT-PCR) analysis 
revealed that the pro-apoptotic lncRNA (named lncRpa) 
and the apoptosis-related circRNA (named circRar1) were 
upregulated in the hippocampus and cerebral cortex of 
mice with lead-induced neurotoxicity. A similar upregu-
lation of lncRpa and circRar1 was observed in N2a cells 
treated with lead acetate (PbAc). We found that lncRpa and 
circRar1 acted via the common target miR-671 to promote 
neuronal apoptosis. These findings highlight the regula-
tory roles of lncRNAs and circRNAs in lead-induced neu-
rotoxicity and provide the first evidence of these ncRNAs 




The mouse model of lead-induced neurotoxicity has been 
previously described, and the animal studies were approved 
by the Animal Care and Use Committee of Guangzhou 
Medical University (Nan et al. 2016). We also used mouse 
neuroblastoma N2a cells exposed to PbAc at a concentra-
tion of 0.1 µM for 48 h as an in vitro model of lead-induced 
neurotoxicity (Nan et al. 2016).
RNA extraction
RNA was obtained from brain tissue (cerebellum, pons, 
medulla oblongata, hippocampus, and cerebral cortex) of 
mice with lead-induced neurotoxicity (2 and 5 weeks of 
exposure to PbAc) and control mice. Trizol reagent (Inv-
itrogen, Carlsbad, CA, USA) was used according to the 
manufacturer’s instructions to extract total RNA from tis-
sues and cells. For quantitation of circRNAs, RNase R 
(Epicentre, Madison, WI, USA) was added to degrade 
linear RNAs. RNA quality and concentration were meas-
ured with a NanoDrop1000 spectrophotometer (NanoDrop 
Technologies, Wilmington, DE, USA).
High‑throughput RNA sequencing
The HiSeq 2000 sequencing platform (Illumina, San 
Diego, CA, USA) was used for high-throughput RNA 
sequencing. The protocol involved removal of rRNA, fol-
lowed by synthesis of double-stranded cDNA and end 
repair. After linking sequencing adaptors and selecting 
fragments, the second strand of cDNA was degraded and 
the remaining strand was enriched by PCR. The quality of 
the library was confirmed by sequencing. A bioinformatic 
analysis of the raw sequencing data was carried out. Dif-
ferentially expressed ncRNAs were searched in the NCBI 
database (http://www.ncbi.nlm.nih.gov/) to determine their 
genome loci.
qRT‑PCR
The Goscript Reverse Transcription System (Promega, 
Madison, WI, USA) was used to reverse transcribe lncR-
NAs, circRNAs, and mRNAs to cDNA. Go Taq qPCR 
Master Mix (Promega) was used for qRT-PCR. All-in-one 
miRNA qRT-PCR Detection kit (Genecopoeia, Rockville, 
MD, USA) was used to reverse transcribe and amplify 
miRNAs. Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) was used as an internal control for the relative 
quantitation of lncRNAs, circRNAs, and mRNAs, whereas 
U6 was used for miRNAs. The detection of internal con-
trol gene GAPDH would be affected after treating with 
RNase R; we divided the same RNA sample into two uni-
form parts when performing the qRT-PCR experiment. One 
part was treated with RNase R for delinearization; this part 
was for the further detection of circRNA. The other part 
was treated with RNase R-free water for finally detecting 
GAPDH gene. The primer sequences are shown in Sup-
plementary Table 3. The 2−ΔΔCt method was used to deter-
mine relative expression levels.
RNA interference and overexpression
LncRNA and circRNA expression was suppressed by 
siRNA-mediated knockdown. Three different siRNAs were 
designed and tested for both lncRpa and circRar1. Over-
expression vectors for lncRpa and circRar1 were also 
constructed (BersinBio, Guangzhou, China). CircRNA 
upstream intron cyclization component (526 bp), circRNA 
(462 bp) and circRNA downstream intron cyclization com-
ponent (804 bp) were included in circRNA expression area. 
BamHIand Hind III were jointly connected to expression 
vector pcDNA 3.1+ through double enzyme connection. 
Overexpression and siRNA sequences are shown in Supple-
mentary Table 1. A specific inhibitor and mimic (RiboBio, 
Guangzhou, China) were used to inhibit or induce miR-671 
expression, respectively. Cells were transfected with plas-
mid using EndoFectin Lenti reagent (Genecopoeia). Ribo-
FECT CP Transfection kit (166T) (RiboBio) was used for 
the miR-671 inhibitor and mimic.
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Detection of cell apoptosis by FCM
The Annexin V-fluorescein isothiocyanate (FITC) apopto-
sis assay kit (KeyGen Biotech, Nanjing, China) was used 
according to the manufacturer’s instructions to detect 
apoptotic cells 48 h after transfection and PbAc treatment. 
Briefly, 5 × 105 cells were collected and resuspended 
in 100 μl 1 × binding buffer. Five microliters Annexin 
V-FITC and 5 μl propidium iodide staining solution were 
added to the cells, followed by incubation at room tempera-
ture (shielded from light) for 10 min. Four hundred micro-
liters 1 × binding buffer was added to the reaction, and 
cells were analyzed by FCM (BD Biosciences, Franklin 
Lakes, NJ, USA) within 1 h.
Detection of cell apoptosis by TUNEL assay
A TUNEL kit (Roche Diagnostics, Indianapolis, IN, USA) 
was used to detect apoptotic cells. Cells were cultured 
on Lab-Tek chambered slides (Thermo Fisher Scientific, 
Waltham, MA, USA). Following treatment, the samples 
were washed twice with phosphate-buffered saline (PBS) 
and fixed with 4 % paraformaldehyde at room temperature 
for 20 min, followed by two washes with PBS. Protein-
ase K (20 μg/ml; Sangon Biotech, Shanghai, China) was 
added, and the slides were covered with a film and incu-
bated at 37 °C for 20 min and then washed twice with PBS. 
The TUNEL reaction mixture (enzyme and labeling solu-
tions at a 1:9 ratio) was added to the slides, which were 
covered with film and incubated at 37 °C for 60 min. After 
three washes with PBS, converter-peroxidase was added 
at 37 °C for 30 min; after three more washes with PBS, 
diaminobenzidine reagent (Roche Diagnostics) was added 
at room temperature for 10 min. The samples were washed 
three times with PBS and counterstained with hematoxylin 
for 10 s and then washed with running water. After dehy-
dration in a graded series of alcohol, the samples were 
dried and mounted with neutral balsam. Nuclei with yel-
lowish brown staining were positive (apoptotic), and hema-
toxylin-counterstained intact nuclei appeared blue under a 
light microscope.
CCK‑8 cell viability assay
The CCK-8 assay kit (Beyotime Institute of Biotechnol-
ogy, Shanghai, China) was used to assess cell viability. 
Cells were harvested in logarithmic phase, and 100 μl 
of the suspension (~2000 cells) were seeded in each well 
of a 96-well plate and incubated overnight at 37 °C and 
5 % CO2. EndoFectin Lenti reagent, plasmids, siRNAs, 
and serum-free Dulbecco’s Modified Eagle’s Medium 
(DMEM; HyClone, Logan, UT, USA) equilibrated to 
15–25 °C were added to the wells followed by incuba-
tion at room temperature for 10–25 min. The medium was 
changed after 6 h, and 0.1 μM PbAc solution was added 
for 48 h. Ten microliters CCK-8 solution was added for 
1–4 h, and the absorbance at 450 nm was measured using a 
microplate reader.
Western blotting
Total protein was extracted using a commercial kit (KeyGen 
Biotech). Protein samples (4–8 μg/μl) were mixed with a 
4:1 ratio of 5 × loading buffer and β-mercaptoethanol and 
stored at −80 °C until use. Proteins (40–60 μg per well) 
were separated by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (100–120 V). A protein marker with a 
molecular weight range of 16–220 kDa was used as refer-
ence. The proteins were transferred to a polyvinylidene dif-
luoride membrane (Merck Millipore, Billerica, MA, USA) 
at 200 mA using a wet membrane-transfer device (Bio-
Rad, Hercules, CA, USA). The membrane was washed 
with Tris-buffered saline containing 0.1 % Tween-20 
(TBST) for 1–2 min and then blocked at room temperature 
for 60 min with TBST containing 5 % non-fat milk powder. 
After overnight incubation at 4 °C with primary antibod-
ies, the membrane was washed with TBST three times for 
15 min. The membrane was then incubated at room temper-
ature for 60 min with secondary antibody and washed three 
times with TBST for 15 min each. Protein bands were visu-
alized using the BeyoECLPlus chemiluminescence reagent 
(Beyotime Institute of Biotechnology) followed by expo-
sure to X-ray film. Primary antibodies against the following 
proteins were used in this study: caspase3 (Cell Signaling 
Technology, Danvers, MA, USA), caspase9 (Epitomics, 
Burlingame, CA, USA), Akt2 (Cell Signaling Technology), 
caspase 8 (Proteintech, Rosemont, IL, USA), and p38 (Cell 
Signaling Technology). The secondary antibody was horse-
radish peroxidase-conjugated IgG (Boster Bio, Pleasanton, 
CA, USA).
FISH
Cells grown on coverslips were fixed with 4 % paraformal-
dehyde at room temperature for 15 min, washed twice with 
0.1 % diethylpyrocarbonate solution and treated with 0.5 % 
Triton X-100 at room temperature for 5 min. The samples 
were dehydrated in a graded series of alcohol and air-dried. 
After adding probe hybridization solution, the samples 
were mounted, denatured at 73 °C for 3 min, and hybrid-
ized in a humid and dark environment at 37 °C for 12–16 h 
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with Cy3-labeled miRNA probe, 6-carboxyfluorescein-
labeled circRNA probe, and Cy5-labeled lncRNA probe 
(BersinBio). The samples were washed three times with 
a pre-heated (43 °C) solution consisting of 50 % forma-
mide and 2× saline sodium citrate (SSC), and then washed 
twice with 2× SSC (37 °C). After counterstaining with 4′, 
6-diamidino-2-phenylindole, the samples were mounted 
with fluorescence mounting medium and imaged with a 
microscope.
Dual luciferase reporter gene assay
Cells were seeded and incubated for 24 h. At 80–90 % con-
fluence, the cells were transfected with firefly and Renilla 
luciferase plasmids. After washing with PBS, passive lysis 
buffer (PLB) was added and cells were incubated at room 
temperature for 15 min, with a micro-oscillator used to 
lyse the cells. Lysates were centrifuged at 10,000 rpm for 
5 min at 4 °C. The supernatants were removed, and 20 μl 
sample were transferred to a 96-well plate and mixed with 
100 μl Dual-Glo Luciferase Assay System (Promega), with 
cell lysis buffer used as the control. The relative light units 
were measured before and after adding 100 μl Stop & Glo 
reagent.
RNA antisense purification (RAP)
The RAP kit (BersinBio) was used for this experiment. 
RAP employs specific biotinylated probes that hybrid-
ize to target RNAs (mRNAs or miRNAs); these can then 
be pulled down, reverse transcribed to cDNA, and identi-
fied by qRT-PCR or sequencing. A total of 107 cells were 
washed with PBS and cross-linked by ultraviolet irradiation 
at 254 nm (0.15 J cm−2). Cells were lysed with 1 ml lysis 
buffer and fully homogenized with a 0.4 mm syringe. Two 
different 45-bp biotinylated antisense probes (0.2 nmol) 
were added to the lncRNA-RAP system and one 50-bp 
biotinylated antisense probe (0.2 nmol) targeting the adap-
tor sequence was added to the circRNA-RAP system. The 
probes were denatured at 65 °C for 10 min and hybrided 
at room temperature for 2 h before adding 200 µl streptavi-
din-coated magnetic beads. Non-specifically bound RNAs 
were removed by washing, and Trizol reagent was used 
to recover miRNAs specifically interacting with ncRNAs. 
PCR and qRT-PCR were used to analyze binding strength 
after reverse transcribing the miRNAs. The probes are 
shown in Supplementary Table 4.
Statistical analysis
Data are presented as mean ± SD. All experiments were 
performed at least three times, and western blotting, 
TUNEL, FCM, and FISH results are representative of three 
independent experiments. The unpaired t test was used for 
statistical analyses. * represents statistically significant dif-
ference (p < 0.05). ** represents highly statistically signifi-
cant difference (p < 0.01). Data were analyzed using SPSS 
v.19.0 software (IBM, Armonk, NY, USA).
Results
Identification of lncRNAs and circRNAs differentially 
expressed in lead‑induced neurotoxicity
A mouse model of lead-induced neurotoxicity was estab-
lished by PbAc exposure (Nan et al. 2016), and high-
throughput RNA sequencing was carried out using the 
brain tissues of these mice. Three lncRNAs and two cir-
cRNAs showing more significant differences in expres-
sion between lead-injured mice and controls—includ-
ing lncRNA TCONS00001596 (named lncRpa), lncRNA 
Gm16025 (ENSMUST00000161282), lncRNA Gm14260 
(ENSMUST00000125121), and the circRNAs (located 
at chr1_75418457_75418970_+, named circRar1) and 
Trerf1 (located at chr17_47315500_47316549_ +)—
were selected for further analysis. The expression of 
these five molecules in the cerebellum, pons, medulla 
oblongata, hippocampus, and cerebral cortex was 
evaluated by qRT-PCR (Fig. 1a–e). The expression of 
Gm16025 was downregulated in the cerebellum, while 
that of the other four RNAs was unaltered (Fig. 1a). 
None of the RNAs were differentially expressed in the 
pons and medulla oblongata between injured and control 
animals (Fig. 1b, c). LncRpa, Gm14260, and circRar1 
levels were markedly upregulated in the hippocampus, 
while Gm16025 was downregulated and circRNA Trerf1 
level showed no change upon injury (Fig. 1d). In the cer-
ebral cortex, lncRpa, circRar1, and Trerf1 were upregu-
lated while no changes in Gm16025 or Gm14260 were 
observed (Fig. 1e). LncRpa and circRar1 expression 
was also upregulated in lead-treated N2a mouse nerve 
cells(Nan et al. 2016), with higher levels observed for 
the former (Fig. 1f). The genomic loci of lncRpa and cir-
cRar1 were determined (Fig. 1g, h).
LncRpa and circRar1 promote apoptosis 
in lead‑induced neurotoxicity
We studied lncRpa and circRar1 functions by their 
overexpression and knockdown in N2a cells. Three 
short interfering RNAs (siRNAs) as well as overexpres-
sion constructs (Supplementary Table 1) were designed 
for each of lncRpa and circRar1. The efficiency of 
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knockdown and overexpression was evaluated by qRT-
PCR. SiRNA1 and siRNA 2 were more efficient at sup-
pressing lncRpa or circRar1 expression than siRNA 3 
(Fig. 2a), and were used in subsequent experiments. 
Both lncRpa and circRar1 overexpression constructs 
resulted in higher levels of these two ncRNAs in N2a 
cells (Fig. 2a). The viability of cells with knockdown 
or overexpression of lncRpa or circRar1 was evalu-
ated before and after PbAc exposure with Cell Count-
ing Kit-8 (CCK-8)(Fig. 2b), while cell apoptosis was 
assessed by flow cytometry (FCM) (Fig. 2c, d), terminal 
deoxynucleotidyl transferase dUTP nick end labeling 
(TUNEL) (Fig. 2e, f), and detection of caspase9 and 
caspase3 expression by western blotting (Fig. 2g, h). 
The rate of apoptosis was higher in the negative con-
trol siRNA (NC) + PbAc group than in untreated cells, 
an effect that was mitigated by lncRpa and circRar1 
knockdown prior to PbAc treatment. On the other hand, 
lncRpa and circRar1 overexpression increased apopto-
sis in PbAc-treated cells relative to those overexpress-
ing an empty vector as NC. These results suggest that 
lncRpa and circRar1 promote apoptosis in lead-induced 
neurotoxicity.
LncRpa and circRar1 interact directly with miR‑671
To clarify the mechanism underlying the stimulatory 
effects of lncRpa and circRar1 in lead-induced apoptosis, 
we used fluorescence in situ hybridization (FISH) (Sup-
plementary Table 2) to visualize the cellular distribution 
of these two molecules (Fig. 3a). LncRpa and circRar1 
were both expressed in the cytoplasm, suggesting that they 
Fig. 1  Identification of differ-
entially expressed ncRNAs and 
their genomic loci. a–e Relative 
expression of five genes dif-
ferentially expressed in the a 
cerebellum, b pons, c medulla 
oblongata, d hippocampus, and 
e cerebral cortex of mice with 
lead-induced neurotoxicity, as 
detected by qRT-PCR. Tissues 
from mice not treated with 
PbAc were used as a control. f 
Relative expression of lncRpa 
and circRar1 in a cellular model 
of lead-induced neurotoxic-
ity. Cells not treated with 
PbAc were used as a control. g 
LncRpa gene locus map. The 
lncRNA contains introns and 
the Zfp825 gene promoter. 
Different exon regions are 
represented by zfp72, zfp825 
4/4, zfp825 2/4, and erap1. h 
CircRar1 gene locus map. The 
circRNA is located in an intron; 
des, Speg 25/41, Speg 27/41, 
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function via post-transcriptional mechanisms. We identified 
miRNAs that were predicted to interact with lncRpa and 
circRar1 using miRanda, Target Scan, and RegRNA (Pad-
mashree and Swamy 2015; Hsu et al. 2007; Huang et al. 
2006). Alignment of these miRNAs with seed sequences 
revealed that miR-671 and miR-218 interacted with both 
lncRpa and circRar1 (Fig. 3b). The dual luciferase reporter 
assay revealed that these miRNAs interact directly with 
lncRpa and circRar1, with miR-671 showing stronger 
binding to lncRpa and circRar1 (Fig. 3c). RNA antisense 
purification (RAP) and transcriptome sequencing analyses 
indicated that only miR-671 was a shared target of lncRpa 
and circRar1. The miRNAs identified by RAP were ana-
lyzed by qRT-PCR and gel electrophoresis. Compared to 
the input group with no RAP probe, miR-671 was present, 
whereas miR-218 was absent in the RAP group (Fig. 3d). 
Moreover, lncRpa and circRar1 bound miR-671 in the RAP 
but not the control group (Fig. 3e). These results indicate 
that lncRpa and circRar1 interact directly and specifically 
with miR-671.
LncRpa and circRar1 regulate miR‑671 expression
The cellular localization of lncRpa, circRar1, and miR-
671 was evaluated by FISH using the probes (Supplemen-
tary Table 2). All three molecules were co-expressed in the 
cytoplasm of N2a cells in the same pattern (Fig. 4a). In 
order to investigate the interaction between the three mol-
ecules, miR-671 was overexpressed or knocked down and 
lncRpa and circRar1 levels were evaluated by qRT-PCR. 
MiR-671 suppression resulted in the upregulation of lncRpa 
and circRar1, whereas miR-671 overexpression inhibited 
their expression (Fig. 4b). We also assessed the interaction 
between the three molecules by altering the expression lev-
els of lncRpa or circRar1 and observing the effect on the 
expression of the other two molecules. We found that miR-
671 expression was upregulated whereas that of circRar1 
was downregulated upon lncRpa knockdown. On the other 
hand, lncRpa overexpression resulted in a decrease in miR-
671 and increase in circRar1 levels (Fig. 4c). Similarly, 
circRar1 suppression increased miR-671 and decreased 
lncRpa expression whereas circRar1 overexpression had 
the opposite effect (Fig. 4d). These results suggest nega-
tive regulation between lncRpa/circRar1 and miR-671 
and a positive regulatory relationship between lncRpa and 
circRar1.
MiR‑671 inhibits apoptosis
To clarify the role of miR-671 in lead-induced neurotoxic-
ity in mice, miR-671 expression was assessed by qRT-PCR. 
The level of miR-671 was downregulated in the hippocam-
pus and cerebral cortex (Fig. 5a) as well as in N2a cells 
treated with PbAc (Fig. 5b). Apoptosis in N2a cells over-
expressing miR-671 with or without PbAc treatment was 
assessed by FCM (Fig. 5c, d), TUNEL staining (Fig. 5e, f), 
and western blot analysis of caspase9 and caspase3 expres-
sion (Fig. 5g, h). MiR-671 overexpression inhibited apopto-
sis according the results of all of the assays. These results 
indicate that lncRpa and circRar1 promote apoptosis via 
regulation of miR-671.
MiR‑671 regulates apoptosis‑associated factors
Target mRNAs of miR-671 were predicted using RegRNA 
software. Five apoptosis-associated genes including 
Akt2,caspase8, p38, Myc-associated factor X (MAX), and 
Ras protein-specific guanine nucleotide releasing factor 
1 (RASGRF1) were identified (Fig. 6a). The dual lucif-
erase reporter gene assay was used to determine whether 
there was a direct interaction between miR-671 and each 
target (Fig. 6b). MiR-671 overexpression and inhibition in 
N2a cells resulted in the down- and upregulation of Akt2, 
caspase8 and p38 levels, respectively (Fig. 6c). We also 
found that the expression of caspase8 and p38 protein was 
inversely proportional and that of Akt2 was directly pro-
portion to miR-671 expression (Fig. 6d, e). Previous stud-
ies have demonstrated the apoptosis-inhibiting function 
of miR-671; Akt2 is presumed to inhibit while caspase8 
and p38 stimulate apoptosis. Thus, miR-671 inhibits neu-
ronal apoptosis via regulation of apoptosis-associated fac-
tors. The discrepancy between Akt2 mRNA and protein 
Fig. 2  Effects of lncRpa and circRar1 on lead-induced neuronal 
apoptosis. a LncRpa and circRar1 were knocked down by siRNA 
or overexpressed (OE) in N2a cells; expression levels were detected 
by qRT-PCR. Overexpression efficiencies of lncRpa and circRar1 
were >200 %. b Viability of lead-treated N2a cells, as detected 
by CCK-8. c Apoptosis in lead-treated N2a cells, as determined by 
FCM using annexin V-FITC/PI. LR, early-stage apoptotic cells; UL, 
necrotic cells; UR, late-stage apoptotic and necrotic cells; LL, liv-
ing cells. d Quantitative analysis of apoptosis rate, calculated as 
the sum of UR % and LR %. e Detection of apoptosis at the chro-
mosome level by the TUNEL assay. Brown nuclei are positive; 
intact nuclei stained with hematoxylin are blue. f Apoptotic index 
based on TUNEL. Five high-power fields (400 ×) of positive cells 
were counted and are shown as the percentage of all positive cells 
(n = 500). g Caspase9 and caspase3 expression in lead-treated N2a 
cells, as determined by western blotting. Control and NC represent 
transfection reagent and empty vector control groups, respectively. h 
Quantitative analysis of results shown in panel (g)
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Fig. 3  Identification of lncRpa and circRar1 target miRNAs. a 
Detection of lncRpa and circRar1 by FISH. Green represents FISH 
probes of lncRpa and circRar1. Nuclei are counterstained with DAPI 
(blue). b Alignment of lncRpa and circRar1 and the seed sequences 
of miR-671 and miR-218. WT, wild-type sequence; Mut, sequence 
mutated in the dual luciferase reporter gene assay. c Dual luciferase 
assay. WT, wild-type vector; Mut, mutated vector; NC, blank con-
trol; miRNA mimic, miR-671 overexpression. d Identification of tar-
get miRNAs by RAP. No RAP probes were used for the input con-
trol. e Percentage of purified miRNAs relative to the input group, as 
detected by qRT-PCR. NC represents control only with beads (color 
figure online)
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expression may be due to post-transcriptional regulation by 
factors other than miR-671 (Kim et al. 2007).
LncRpa and circRar1 regulate apoptosis‑associated 
factors in lead‑induced neurotoxicity
To confirm the mechanistic basis for the pro-apoptotic 
function of lncRpa and circRar1 in lead-induced neuro-
toxicity, the mRNA levels of Akt2, caspase8, and p38 were 
evaluated in N2a cells exposed to PbAc (Fig. 7a). The 
transcript levels of all three genes were increased by PbAc 
treatment, whereas the protein expression of caspase8 and 
p38 was increased and that of Akt2 was decreased under 
these conditions (Fig. 7b, c). To investigate the relationship 
between lncRpa and circRar1 and apoptotic proteins, we 
knocked down or overexpressed lncRpa and circRar1. The 
mRNA levels of Akt2, caspase8, and p38 were decreased 
by lncRpa or circRar1 knockdown, whereas their overex-
pression increased the transcript levels of the three targets 
(Fig. 7d). The protein levels of caspase8 and p38 were 
decreased, whereas that of Akt2 was increased by loss of 
lncRpa or circRar1 (Fig. 7e, f); the opposite trends were 
observed upon lncRpa or circRar1 overexpression. These 
data suggest that joint targeting of miR-671 by lncRpa 
and circRar1 is not the primary reason for the discrepancy 
between Akt2 mRNA and protein expression. Moreover, 
our findings indicate that lncRpa and circRar1 target cas-
pase8 and p38 via miR-671 to induce neuronal apoptosis 
upon lead toxicity.
Discussion
High-throughput sequencing technology has broadened 
our understanding of gene regulatory networks. Whole 
genome sequencing has revealed that about 93 % of the 
genome is transcribed as RNA, but only 2 % encode 
proteins (Birney et al. 2007). Although the total num-
ber of nucleotides in the human genome is 30 times that 
of the nematode genome, the number of protein-coding 
sequences is comparable, which highlights the importance 
of ncRNA sequences in the regulation of eukaryotic gene 
expression (Costa 2008).
Environmental toxins such as lead can adversely affect 
human health, but the molecular mechanisms of lead-
induced neurotoxicity are not well understood. Most 
research in this area has focused on the role of mRNAs 
(Soliman et al. 2015; Gao et al. 2016) or miRNAs (Li 
et al. 2015; Martinez-Pacheco et al. 2014), and there is 
little, if any information on how lncRNAs and circRNAs 
are involved in lead-induced neurotoxicity. The roles of 
ncRNAs have been extensively investigated in the context 
of carcinogenesis and cancer development (Cheng et al. 
2015). For example, H19 is aberrantly expressed in many 
types of cancer such as liver and bladder cancers and pan-
creatic ductal carcinoma (Ma et al. 2014; Luo et al. 2013; 
Tsang and Kwok 2007), while HOTAIR has been impli-
cated in various aspects of cancer development (Wu et al. 
2014). Genome-wide association studies have shown that 

















































































































Fig. 4  Interaction of lncRpa, circRar1 and miR-671. a Co-locali-
zation of lncRpa (magenta), circRar1 (green), and miR-671 (red) in 
N2a cells. Nuclei were counterstained with DAPI (blue). b–d Overex-
pression (OE; using a mimic for miR-671 and overexpression vectors 
for lncRpa and circRar1) and siRNA-mediated knockdown of b miR-
671, c lncRpa, and d circRar1 (color figure online)






























































































































































(Cheetham et al. 2013). Less is known about circRNAs, 
despite their prevalence in mammalian cells. These mol-
ecules also regulate gene expression at the post-transcrip-
tional level (Memczak et al. 2013), and some have been 
found to be associated with tumors (Hansen et al. 2013b; 
Peng et al. 2015; Zhao and Shen 2015).
NcRNAs interact in a complex regulatory network (Sup-
plementary Fig. 1). LncRNAs alter chromatin structure via 
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activation and transport of relevant proteins (Zhao et al. 
2008; Tsai et al. 2010; Yao et al. 2010) and are also involved 
in the regulation of transcription factors (Hung et al. 2011) 
and mRNA and protein expression (Gong and Maquat 2011; 
Yoon et al. 2012). In many instances, lncRNAs carry out 
their functions by modulating the expression of miRNAs 
at the level of transcription, post-transcription, or splicing 
(Poliseno et al. 2010; Augoff et al. 2012; Steck et al. 2012; 
Wang et al. 2010). MiRNAs play a critical role in this regu-
latory network by directly targeting mRNAs (Orom et al. 
2008). Previous studies have shown that miRNAs can be 
adsorbed by circRNAs, which act as endogenous miRNA 
competitors (Hansen et al. 2013a, b; Xu et al. 2015).
Fig. 5  Analysis of miR-671 function. a, b Downregulation of miR-
671 expression in the hippocampus and cerebral cortex in a mouse 
model of lead-induced neurotoxicity (a) and in PbAc-treated N2a 
cells (b). Controls were tissue from mice and N2a cells that were 
not treated with PbAc. c Apoptosis of N2a cells expressing miR-671 
mimic, as determined by FCM using annexin V-FITC/PI. NC, trans-
fection reagent negative control group. d Quantitative analysis of 
apoptosis rate, calculated as the sum of UR % and LR %. e Apopto-
sis of N2a cells overexpressing miR-671, as detected with TUNEL. f 
Apoptotic index calculated from results in panel (e). g Caspase9 and 
caspase3 expression in N2a cells overexpressing miR-671, as deter-
mined by western blotting. Control, solvent control; NC, transfection 
reagent control; control + PbAc, PbAc treatment; mimic + PbAc, 
PbAc treatment after miR-671 overexpression; NC + PbAc, transfec-
tion reagent control with PbAc treatment. h Quantitative analysis of 







































































































Fig. 6  MiR-671 target mRNAs and proteins. a Alignment of miR-671 
and seed sequences of Akt2, caspase 8, p38, myc-associated factor 
(MA)X, and Ras protein-specific guanine nucleotide releasing fac-
tor (RASGRF)1. WT, wild-type sequences; Mut, sequence mutated 
in the dual luciferase reporter gene assay. b Luciferase reporter gene 
assay. WT, wild-type vector; Mut, mutated vector; NC, blank con-
trol; miRNA mimic, miRNA overexpression. c MRNA expression of 
Akt2, caspase 8, and p38. NC, transfection reagent negative control; 
mimic, miR-671 overexpression; inhibitor, miR-671 knockdown. d 
Expression of Akt2, caspase 8, and p38 protein. Control, blank con-
trol; mimic, miR-671 overexpression; mimic NC, control for miR-671 
overexpression; inhibitor, miR-671 knockdown; inhibitor NC, control 
for miR-671 knockdown. e Quantitative analysis of results shown in 
panel (d)
◂
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In this study, we found that lncRNA lncRpa and cir-
cRNA circRar1 were differentially expressed in lead-
induced neurotoxicity and directly regulated miR-671 
expression to promote neuronal apoptosis via upregula-
tion of the pro-apoptotic proteins caspase8 and p38. We 
also found that miR-671 negatively regulate circRar1 and 
lncRpa. Thus, lncRpa and circRar1 jointly target miR-671 
to modulate the expression of apoptosis-associated pro-
teins in lead-induced neuronal apoptosis. These findings 
highlight a new mechanism of lead-induced neurotoxicity 
and provide a insight for the future investigations of the 
pathological process.
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Fig. 7  Apoptotic proteins regulated by lncRpa and circRar1 in lead-
induced neurotoxicity. a Expression of Akt2, caspase 8, and p38 
mRNA, as determined by qRT-PCR. NC, cells not treated with PbAc. 
b Expression of Akt2, caspase 8, and p38 protein, as determined by 
western blotting. NC, cells not treated with PbAc. c Quantitative 
analysis of results shown in panel (b). d Changes in Akt2, caspase 8, 
and p38 mRNA expression after knockdown and overexpression of 
lncRpa and circRar1, as determined by qRT-PCR. NC, transfection 
reagent negative control. e Akt2, caspase 8, and p38 protein expres-
sion after knockdown and overexpression of lncRpa and circRar1, as 
determined by western blotting. Control and NC represent transfec-
tion reagent and empty vector negative control groups, respectively. f 
Quantitative analysis of results shown in panel (e)
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